Patients with anemia may develop a chronic anemia that impacts the quality of life, and some of these patients may benefit from administration of recombinant erythropoietin. Ludwig et al identified factors indicating the likelihood of response to erythropoietin administration. The authors are from Vienna and Graz in Austria.

To read more or access our algorithms and calculators, please log in or register.